Cargando…

C-REACTIVE PROTEIN AS A BIOMARKER FOR IMPROVED EFFICACY OF LENZILUMAB IN PATIENTS WITH COVID-19: RESULTS FROM THE LIVE-AIR TRIAL

Detalles Bibliográficos
Autores principales:	TEMESGEN, ZELALEM, BURGER, CHARLES, BAKER, JASON, POLK, CHRISTOPHER, LIBERTIN, CLAUDIA, KELLEY, COLLEEN, MARCONI, VINCENT, ORENSTEIN, ROBERT, CATTERSON, VICTORIA, ARONSTEIN, WILLIAM, DURRANT, CAMERON, CHAPPELL, DALE, CHAPPELL, GABRIELLE, AHMED, OMAR, BADLEY, ANDREW
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians. Published by Elsevier Inc. 2021
Materias:	Late Breaking
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503207/ http://dx.doi.org/10.1016/j.chest.2021.08.029

Ejemplares similares

Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial
por: Temesgen, Zelalem, et al.
Publicado: (2022)

40. Lenzilumab Efficacy and Safety in Newly Hospitalized COVID-19 Subjects: Results From a Phase 3 Randomized Double-Blind Placebo-Controlled Trial
por: Temesgem, Zelalem, et al.
Publicado: (2021)

LENZILUMAB EFFICACY AND SAFETY IN NEWLY HOSPITALIZED COVID-19 SUBJECTS: RESULTS FROM THE LIVE-AIR PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
por: Temesgen, Zelalem, et al.
Publicado: (2021)

C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: results from the randomised phase 3 ‘LIVE-AIR’ trial
por: Temesgen, Zelalem, et al.
Publicado: (2023)

1134. Lenzilumab Treatment in COVID-19 Pneumonia Reduces Circulating Cytokines and Markers of Systemic Inflammation
por: Chappell, Dale, et al.
Publicado: (2022)

GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study
por: Temesgen, Zelalem, et al.
Publicado: (2020)

In Reply — Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019
por: Temesgen, Zelalem, et al.
Publicado: (2021)

P737: LENZILUMAB AND AZACITIDINE IMPROVE HEMATOLOGIC ALTERATIONS OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE PREACH-M TRIAL
por: Ross, David, et al.
Publicado: (2023)

Immunonutrition as a component of immunomodulating program in the elderly patients in non-Covid-19 hospital
por: Arykan, N., et al.
Publicado: (2020)

COVID-19 and Long-Term Care Healthcare Worker Mental Health in Rhode Island
por: Kohn, Robert, et al.
Publicado: (2021)

DESCRIBING THE EFFECT OF THE COVID-19 PANDEMIC ON TB CARE IN UGANDA: A CROSS-SECTIONAL STUDY
por: BBUYE, MUDARSHIRU, et al.
Publicado: (2021)

INVESTIGATION BETWEEN THE ASSOCIATION OF CALCIUM CHANNELS BLOCKERS ON MORTALITY AND INTUBATION IN PATIENTS WITH COVID-19
por: DOUEN, AARON, et al.
Publicado: (2021)

HEMATOLOGICAL FINDINGS AND RELATED TREATMENT OF 877 PATIENTS HOSPITALIZED WITH COVID-19 IN A SINGLE ACUTE CARE HOSPITAL IN QUEENS COUNTY, NEW YORK
por: KARASS, MICHAEL, et al.
Publicado: (2021)

DEMOGRAPHICS AND CLINICAL CHARACTERISTICS OF 877 PATIENTS HOSPITALIZED WITH COVID-19 IN A SINGLE ACUTE CARE HOSPITAL IN QUEENS COUNTY, NEW YORK
por: KARASS, MICHAEL, et al.
Publicado: (2021)

ORAL GARGLE OF ETHANOL-BASED MOUTHWASH SOLUTION AND ITS EFFECTS ON ADULT PATIENTS WITH MILD COVID-19 INFECTION: AN OPEN LABEL-RANDOMIZED CONTROLLED TRIAL
por: CYRIL VITUG, LAWRENCE, et al.
Publicado: (2021)

SURGICAL TREATMENT OF PATIENTS WITH SEVERE LUNG INFECTIONS IN THE CONTEXT OF COVID-19 PANDEMIC
por: YERMASHKEVICH, SIARHEI, et al.
Publicado: (2021)

COVID-19 OUTCOMES IN PATIENTS WITH PULMONARY HYPERTENSION: A RETROSPECTIVE COHORT ANALYSIS
por: ASLAM, AHSAN
Publicado: (2021)

RESPIRATORY SEQUELAE AND ASSOCIATED RISK FACTORS AMONG PATIENTS WITH COVID-19 SIX MONTHS AFTER HOSPITAL DISCHARGE
por: KONKOL, SAMUEL, et al.
Publicado: (2021)

CLINICAL CHARACTERISTICS OF 150 CRITICALLY ILL PATIENTS HOSPITALIZED WITH COVID-19 AT A SINGLE ACUTE CARE HOSPITAL IN QUEENS COUNTY BOROUGH OF NEW YORK CITY
por: KARASS, MICHAEL, et al.
Publicado: (2021)

RESILIENCY AS A PROCESS: A QUALITATIVE INVESTIGATION INTO U.S. VETERANS’ EXPERIENCES AGING WITH HIV
por: Chan, Kiera, et al.
Publicado: (2022)

BURDEN OF FALL-RISK INCREASING DRUGS IN OLDER ADULTS PRESENTING WITH FALLS TO THE EMERGENCY ROOM
por: Casey, Martin, et al.
Publicado: (2022)

DOES COVID-19 INCREASE THE RISK OF DEVELOPING CYSTIC LUNG DISEASE?
por: FANOUS, CHRISTINA, et al.
Publicado: (2022)

CPT: Pharmacometrics & Systems Pharmacology
Publicado: (2013)

Late Breaking Abstracts
Publicado: (2019)

IMPACT OF COVID-19 PANDEMIC ON HOUSE-STAFF
por: Tobin-Schnittger, Patrick, et al.
Publicado: (2020)

EXPERIENCE WITH COVID-19 CRITICALLY ILL PATIENTS IN A PRIVATE COMMUNITY HOSPITAL IN PUEBLA CITY, MEXICO
por: Arizpe-Bravo, Daniel, et al.
Publicado: (2020)

COMPARISON OF OROPHARYNGEAL AND NASOPHARYNGEAL SWABS FOR DETECTION OF SARS-COV-2 IN PATIENTS WITH COVID-19
por: Manzoor, Shazli
Publicado: (2020)

EXTRACORPOREAL MEMBRANE OXYGENATION AS RESCUE THERAPY FOR COVID-19 INDUCED HYPOXIA: SINGLE-CENTER STUDY
por: Alnababteh, Muhtadi, et al.
Publicado: (2020)

LUNG ULTRASOUND IN THE SETTING OF COVID-19: A SCOPING LITERATURE REVIEW
por: Yan, Laura Ran, et al.
Publicado: (2020)

TREATMENT ESCALATION DURING THE COVID-19 PANDEMIC: WHAT’S THE PLAN?
por: Thomson, Andrea, et al.
Publicado: (2020)

CLINICAL CHARACTERISTICS OF 537 CASES OF COVID-19 IN DIFFERENT ALTITUDE OF SICHUAN PROVINCE, CHINA: A RETROSPECTIVE STUDY
por: Guo, Lu, et al.
Publicado: (2020)

IMPACT OF FULL DOSE ANTICOAGULATION IN HOSPITALIZED PREDOMINANTLY BLACK PATIENTS WITH SARS-COV-2 INFECTION: A RETROSPECTIVE SINGLE CENTER EXPERIENCE
por: Samaha, Ghassan, et al.
Publicado: (2020)

THE USE OF TOCILIZUMAB AT A COMMUNITY HOSPITAL DURING THE COVID-19 PANDEMIC IN THE EPICENTER OF NORTHERN NEW JERSEY
por: Capo, Aida, et al.
Publicado: (2020)

THE ANTI-INFECTIVE AND IMMUNOMODULATOR PARADOX: INCREASED RISK OF COINFECTION WITH HYDROXYCHLOROQUINE IN CRITICAL PATIENTS WITH COVID-19
por: Trelles Garcia, Daniela, et al.
Publicado: (2020)

RT-PCR FINDINGS IN PATIENTS ADMITTED WITH COVID-19 AT KULSUM INTERNATIONAL HOSPITAL ISLAMABAD, PAKISTAN
por: Manzoor, Shazli, et al.
Publicado: (2020)

INVESTIGATING THE RELATIONSHIP BETWEEN RACE/ETHNICITY AND CLINICAL OUTCOMES IN COVID-19
por: Alnababteh, Muhtadi, et al.
Publicado: (2020)

COVID-19 VENTILATOR DEPENDENT RESPIRATORY FAILURE SUCCESSFULLY TREATED WITH ANTIINFLAMMATORY BOTANICALS
por: Ali, Mir
Publicado: (2020)

PREDICTING THE NEED FOR INVASIVE MECHANICAL VENTILATION IN PATIENTS WITH CORONAVIRUS DISEASE 2019
por: Alnababteh, Muhtadi, et al.
Publicado: (2020)

PNEUMOMEDIASTINUM AS A COMPLICATION OF COVID-19: MAY NOT NEED INTERVENTION
por: Miyakawa, Lina, et al.
Publicado: (2020)

COVID-19 AND COPD: POOLED ANALYSIS OF OBSERVATIONAL STUDIES
por: Venkata, Vikramaditya Samala, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ev3ul59met516ia6t2b234ncq5